Genetic heterogeneity and clonal evolution in acute myeloid leukemia

被引：21

作者：

Romer-Seibert, Jennifer S. ^{[1
]}

Meyer, Sara E. ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Bluemle Life Sci Bldg,Suite 319,233 S 10th St, Philadelphia, PA 19107 USA

来源：

CURRENT OPINION IN HEMATOLOGY | 2021年 / 28卷 / 01期

关键词：

acute myeloid leukemia; clonal dynamics; clonal evolution; single-cell sequencing; tumor heterogeneity;

D O I：

10.1097/MOH.0000000000000626

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose of review Clonal heterogeneity is a significant obstacle to successful treatment of patients with acute myeloid leukemia (AML). Here, we review new advances in the understanding of genetic heterogeneity in AML using single-cell DNA-sequencing technology. Recent findings New genomics and immunologic discovery tools have provided single-cell resolution maps of the clonal architecture of AML. The use of these technologies reveals the mutational landscape of AML at diagnosis, during treatment, and at relapse has an enormous degree of clonal complexity and diversity that is poised to adapt and evolve under environmental pressures. AML is a complex ecosystem of competing and cooperating clones undergoing constant evolution and selection.

引用

页码：64 / 70

页数：7

共 22 条

[1] Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence [J].

Boyd, Allison L. ;

Aslostovar, Lili ;

Reid, Jennifer ;

Ye, Wendy ;

Tanasijevic, Borko ;

Porras, Deanna P. ;

Shapovalova, Zoya ;

Almakadi, Mohammed ;

Foley, Ronan ;

Leber, Brian ;

Xenocostas, Anargyros ;

Bhatia, Mickie .

CANCER CELL, 2018, 34 (03) :483-+

[2] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].

DiNardo, Courtney D. ;

Pratz, Keith ;

Pullarkat, Vinod ;

Jonas, Brian A. ;

Arellano, Martha ;

Becker, Pamela S. ;

Frankfurt, Olga ;

Konopleva, Marina ;

Wei, Andrew H. ;

Kantarjian, Hagop M. ;

Xu, Tu ;

Hong, Wan-Jen ;

Chyla, Brenda ;

Potluri, Jalaja ;

Pollyea, Daniel A. ;

Letai, Anthony .

BLOOD, 2019, 133 (01) :7-17

[3] Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing [J].

Ding, Li ;

Ley, Timothy J. ;

Larson, David E. ;

Miller, Christopher A. ;

Koboldt, Daniel C. ;

Welch, John S. ;

Ritchey, Julie K. ;

Young, Margaret A. ;

Lamprecht, Tamara ;

McLellan, Michael D. ;

McMichael, Joshua F. ;

Wallis, John W. ;

Lu, Charles ;

Shen, Dong ;

Harris, Christopher C. ;

Dooling, David J. ;

Fulton, Robert S. ;

Fulton, Lucinda L. ;

Chen, Ken ;

Schmidt, Heather ;

Kalicki-Veizer, Joelle ;

Magrini, Vincent J. ;

Cook, Lisa ;

McGrath, Sean D. ;

Vickery, Tammi L. ;

Wendl, Michael C. ;

Heath, Sharon ;

Watson, Mark A. ;

Link, Daniel C. ;

Tomasson, Michael H. ;

Shannon, William D. ;

Payton, Jacqueline E. ;

Kulkarni, Shashikant ;

Westervelt, Peter ;

Walter, Matthew J. ;

Graubert, Timothy A. ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

DiPersio, John F. .

NATURE, 2012, 481 (7382) :506-510

[4] How and when to decide between epigenetic therapy and chemotherapy in patients with AML [J].

Dombret, Herve ;

Itzykson, Raphael .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, :45-53

[5] The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML [J].

Dunlap, Jennifer B. ;

Leonard, Jessica ;

Rosenberg, Mara ;

Cook, Rachel ;

Press, Richard ;

Fan, Guang ;

Raess, Philipp W. ;

Druker, Brian J. ;

Traer, Elie .

AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (08) :913-920

[6] Single-cell mutational profiling enhances the clinical evaluation of AML MRD [J].

Ediriwickrema, Asiri ;

Aleshin, Alexey ;

Reiter, Johannes G. ;

Corces, M. Ryan ;

Kohnke, Thomas ;

Stafford, Melissa ;

Liedtke, Michaela ;

Medeiros, Bruno C. ;

Majeti, Ravindra .

BLOOD ADVANCES, 2020, 4 (05) :943-952

[7] Genomic Classification in Acute Myeloid Leukemia [J].

Lemonnier, Francois ;

Inoue, Satoshi ;

Mak, Tak W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (09) :900-900

[8] Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia [J].

Ley, Timothy J. ;

Miller, Christopher ;

Ding, Li ;

Raphael, Benjamin J. ;

Mungall, Andrew J. ;

Robertson, A. Gordon ;

Hoadley, Katherine ;

Triche, Timothy J., Jr. ;

Laird, Peter W. ;

Baty, Jack D. ;

Fulton, Lucinda L. ;

Fulton, Robert ;

Heath, Sharon E. ;

Kalicki-Veizer, Joelle ;

Kandoth, Cyriac ;

Klco, Jeffery M. ;

Koboldt, Daniel C. ;

Kanchi, Krishna-Latha ;

Kulkarni, Shashikant ;

Lamprecht, Tamara L. ;

Larson, David E. ;

Lin, Ling ;

Lu, Charles ;

McLellan, Michael D. ;

McMichael, Joshua F. ;

Payton, Jacqueline ;

Schmidt, Heather ;

Spencer, David H. ;

Tomasson, Michael H. ;

Wallis, John W. ;

Wartman, Lukas D. ;

Watson, Mark A. ;

Welch, John ;

Wendl, Michael C. ;

Ally, Adrian ;

Balasundaram, Miruna ;

Birol, Inanc ;

Butterfield, Yaron ;

Chiu, Readman ;

Chu, Andy ;

Chuah, Eric ;

Chun, Hye-Jung ;

Corbett, Richard ;

Dhalla, Noreen ;

Guin, Ranabir ;

He, An ;

Hirst, Carrie ;

Hirst, Martin ;

Holt, Robert A. ;

Jones, Steven .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) :2059-2074

[9] Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis [J].

Loberg, Matthew A. ;

Bell, Rebecca K. ;

Goodwin, Leslie O. ;

Eudy, Elizabeth ;

Miles, Linde A. ;

SanMiguel, Jennifer M. ;

Young, Kira ;

Bergstrom, David E. ;

Levine, Ross L. ;

Schneider, Rebekka K. ;

Trowbridge, Jennifer J. .

LEUKEMIA, 2019, 33 (07) :1635-1649

[10] Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications [J].

Marando, Ludovica ;

Huntly, Brian J. P. .

CURRENT ONCOLOGY REPORTS, 2020, 22 (06)

← 1 2 3 →